SEI Investments
CRBP icon

SEI Investments’s Corbus Pharmaceuticals CRBP Stock Holding History

SEI Investments’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,589
Closed -$93.4K – 2811
2025
Q1 		$93.4K Buy
+17,589
New +$155K ﹤0.01% 2608
2018
Q3 		– Sell
-371
Closed -$56K – 2644
2018
Q2 		$56K Buy
371
+5
+1% +$908 ﹤0.01% 2473
2018
Q1 		$67K Hold
366
– – ﹤0.01% 2262
2017
Q4 		$78K Hold
366
– – ﹤0.01% 2223
2017
Q3 		$79K Buy
+366
New +$71.6K ﹤0.01% 2152

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

SEI Investments's CRBP Position: Q2 2025 in Review

SEI Investments sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 17,589 shares — an estimated $93.4K sold.

SEI Investments first reported a position in CRBP in Q3 2017 and held it in 5 quarters. The position peaked at $93.4K in Q1 2025. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • SEI Investments reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • SEI Investments sold 17,589 Corbus Pharmaceuticals shares in Q2 2025, an estimated $93.4K.
  • SEI Investments first reported a position in Corbus Pharmaceuticals in Q3 2017 and held it in 5 quarters.
  • SEI Investments's Corbus Pharmaceuticals position peaked at $93.4K in Q1 2025.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on SEI Investments's 13F filing for Q2 2025, filed 14 Aug 2025.